Search Results - "Bereznicki, Luke"

Refine Results
  1. 1

    Development and Validation of an Oral Anticoagulation Knowledge Tool (AKT) by Obamiro, Kehinde O, Chalmers, Leanne, Bereznicki, Luke R E

    Published in PloS one (28-06-2016)
    “…Assessing and improving patients' anticoagulation knowledge can lead to better treatment outcomes. While validated knowledge instruments exist for use in…”
    Get full text
    Journal Article
  2. 2

    Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors by Angamo, Mulugeta Tarekegn, Chalmers, Leanne, Curtain, Colin M., Bereznicki, Luke R. E.

    Published in Drug safety (01-09-2016)
    “…Adverse drug reactions (ADRs) are one of the leading causes of hospital admissions and morbidity in developed countries and represent a substantial burden on…”
    Get full text
    Journal Article
  3. 3

    Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis by Bezabhe, Woldesellassie M., Chalmers, Leanne, Bereznicki, Luke R., Peterson, Gregory M.

    Published in Medicine (Baltimore) (01-04-2016)
    “…The often cited need to achieve ≥95% (nearly perfect) adherence to antiretroviral therapy (ART) for successful virologic outcomes in HIV may present a barrier…”
    Get full text
    Journal Article
  4. 4

    Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia by Bezabhe, Woldesellassie M, Chalmers, Leanne, Bereznicki, Luke R, Peterson, Gregory M, Bimirew, Mekides A, Kassie, Desalew M

    Published in PloS one (14-05-2014)
    “…Antiretroviral therapy (ART) has been life saving for hundreds of thousands of Ethiopians. With increased availability of ART in recent years, achievement of…”
    Get full text
    Journal Article
  5. 5

    Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation by Admassie, Endalkachew, Chalmers, Leanne, Bereznicki, Luke R.

    Published in The American journal of cardiology (01-10-2017)
    “…Suboptimal guideline adherence and underuse of anticoagulants in patients with atrial fibrillation (AF) have been reported worldwide. This study aimed to…”
    Get full text
    Journal Article
  6. 6

    Pharmacist‐led interventions to reduce adverse drug events in older people living in residential aged care facilities: A systematic review by Ali, Sheraz, Salahudeen, Mohammed S., Bereznicki, Luke R. E., Curtain, Colin M.

    Published in British journal of clinical pharmacology (01-10-2021)
    “…Aims We aimed to investigate the efficacy and effectiveness of pharmacist‐led interventions to reduce adverse drug events (ADEs) in older people living in…”
    Get full text
    Journal Article
  7. 7

    Association between anticholinergic drug burden and mortality in older people: a systematic review by Ali, Sheraz, Peterson, Gregory M., Bereznicki, Luke R., Salahudeen, Mohammed S.

    Published in European journal of clinical pharmacology (01-03-2020)
    “…Purpose The purpose of the study is to conduct a systematic review of studies examining the association between anticholinergic burden and mortality in older…”
    Get full text
    Journal Article
  8. 8

    Prediction of Hospitalization due to Adverse Drug Reactions in Elderly Community-Dwelling Patients (The PADR-EC Score) by Parameswaran Nair, Nibu, Chalmers, Leanne, Connolly, Michael, Bereznicki, Bonnie J, Peterson, Gregory M, Curtain, Colin, Castelino, Ronald L, Bereznicki, Luke R

    Published in PloS one (31-10-2016)
    “…Adverse drug reactions (ADRs) are the major cause of medication-related hospital admissions in older patients living in the community. This study aimed to…”
    Get full text
    Journal Article
  9. 9

    A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation by Obamiro, Kehinde O., Chalmers, Leanne, Bereznicki, Luke R. E.

    “…Atrial fibrillation (AF) is a growing public health concern and remains an independent risk factor for ischemic stroke. Warfarin, a commonly used oral…”
    Get full text
    Journal Article
  10. 10

    Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices? by Alamneh, Endalkachew A., Chalmers, Leanne, Bereznicki, Luke R.

    “…Background and Objectives Atrial fibrillation (AF) and the associated risk of stroke are emerging epidemics throughout the world. Suboptimal use of oral…”
    Get full text
    Journal Article
  11. 11

    Outcomes of Medication Misadventure Among People With Cognitive Impairment or Dementia: A Systematic Review and Meta-analysis by Zaidi, Anum Saqib, Peterson, Gregory M., Bereznicki, Luke R.E., Curtain, Colin M., Salahudeen, Mohammed

    Published in Annals of Pharmacotherapy (01-04-2021)
    “…Objective: To investigate mortality and hospitalization outcomes associated with medication misadventure (including medication errors [MEs], such as the use of…”
    Get full text
    Book Review Journal Article
  12. 12

    The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation by Rolls, Chanelle A, Obamiro, Kehinde O, Chalmers, Leanne, Bereznicki, Luke R E

    Published in Cardiovascular therapeutics (01-12-2017)
    “…Patients' knowledge regarding their oral anticoagulant (OAC) treatment for stroke prevention in atrial fibrillation (AF), their level of medication adherence,…”
    Get more information
    Journal Article
  13. 13

    Hospitalization in older patients due to adverse drug reactions -the need for a prediction tool by Parameswaran Nair, Nibu, Chalmers, Leanne, Peterson, Gregory M, Bereznicki, Bonnie J, Castelino, Ronald L, Bereznicki, Luke R

    Published in Clinical interventions in aging (01-01-2016)
    “…Adverse drug reactions (ADRs) represent a major burden on society, resulting in significant morbidity, mortality, and health care costs. Older patients living…”
    Get full text
    Journal Article
  14. 14

    Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey by Obamiro, Kehinde O, Chalmers, Leanne, Lee, Kenneth, Bereznicki, Bonnie J, Bereznicki, Luke R E

    “…Atrial fibrillation (AF) is the most commonly diagnosed arrhythmia in clinical practice, and is associated with a significant medical and economic burden…”
    Get more information
    Journal Article
  15. 15

    The Tasmanian Atrial Fibrillation Study (TAFS): Differences in Stroke Prevention According to Sex by Pilcher, Sophie M., Alamneh, Endalkachew Admassie, Chalmers, Leanne, Bereznicki, Luke R.

    Published in The Annals of pharmacotherapy (01-09-2020)
    “…Background: There are limited Australian data on sex differences in oral anticoagulant (OAC) prescribing in atrial fibrillation (AF) and ongoing debate…”
    Get full text
    Journal Article
  16. 16

    Ten-year trends in adverse drug reaction–related hospitalizations among people with dementia by Zaidi, Anum Saqib, Peterson, Gregory M., Bereznicki, Luke R.E., Curtain, Colin M., Salahudeen, Mohammed S.

    Published in Therapeutic advances in drug safety (01-03-2022)
    “…Aim: Trends in the incidence of adverse drug reaction (ADR)–related hospitalizations have been studied in the general population, but not specifically in…”
    Get full text
    Journal Article
  17. 17

    Switching of oral anticoagulants in patients with nonvalvular atrial fibrillation: A narrative review by Kefale, Adane Teshome, Peterson, Gregory M., Bezabhe, Woldesellassie M., Bereznicki, Luke R.

    Published in British journal of clinical pharmacology (01-02-2022)
    “…Approval of direct‐acting oral anticoagulants (DOACs) for stroke prevention in atrial fibrillation (AF) was an important milestone, providing a wider range of…”
    Get full text
    Journal Article
  18. 18

    The Utilization of Antithrombotic Therapy in Older Patients in Aged Care Facilities With Atrial Fibrillation by Frain, Bridget, Castelino, Ronald, Bereznicki, Luke R.

    Published in Clinical and applied thrombosis/hemostasis (01-04-2018)
    “…Oral anticoagulants are essential drugs for the prevention of thromboembolic events in patients with atrial fibrillation (AF). Anticoagulants are, however,…”
    Get full text
    Journal Article
  19. 19

    Comparing Australian orthopaedic surgeons' reported use of thromboprophylaxis following arthroplasty in 2012 and 2017 by Mirkazemi, Corinne, Bereznicki, Luke R, Peterson, Gregory M

    Published in BMC musculoskeletal disorders (08-02-2019)
    “…It is generally accepted that all arthroplasty patients should receive venous thromboembolism (VTE) and bleeding risk assessments, and that postoperative…”
    Get full text
    Journal Article
  20. 20

    Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study by Angamo, Mulugeta Tarekegn, Curtain, Colin Michael, Chalmers, Leanne, Yilma, Daniel, Bereznicki, Luke

    Published in PloS one (16-10-2017)
    “…Adverse drug reactions (ADRs) are important causes of morbidity and mortality in the healthcare system; however, there are no studies reporting on the…”
    Get full text
    Journal Article